tirzepatide vs semaglutide weight loss trials Versus Semaglutide: A Structured Narrative Review of Direct Comparative Clinical Studies and Post Hoc Analyses on Clinical and Laboratory Outcomes Tirzepatide vs. Semaglutide in Obesity

PlexusDx offers compounded tirzepatide injection at $289/mo month-to-month, or from $249/mo on the 6-month plan, with no membership fees, HSA/FSA eligibility, and availability across all 50 states

At $199/month for compounded semaglutide injections (and as low as $119/month on the six-month bundle), it lands at the mid-to-low end of the market

Quick Take & Core Data: Average body weight reduction: 30.3% at 104 weeks [1] Dose cohort outcome: 45% of patients in the 12 mg group lost 30% or more body weight [1] Diabetic weight loss efficacy: 16.8% reduction over 40 weeks [2] Retatrutide is a triple agonist that binds directly to three metabolic pathways [1, 3]

Bacterial translocation (BT) in cirrhosis

Many standard EVOOs fall below this level, particularly after extended shelf time

PlexusDx compounded semaglutide is prepared by licensed 503A pharmacies in smaller batches and shipped shortly after compounding, maximizing freshness